These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31621520)

  • 1. Assessing variability of antineoplastic drugs handling practices in clinical settings.
    Arnold S; Kaup HM
    J Occup Environ Hyg; 2019 Dec; 16(12):757-762. PubMed ID: 31621520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial and Temporal Variability in Antineoplastic Drug Surface Contamination in Cancer Care Centers in Alberta and Minnesota.
    Jeronimo M; Arnold S; Astrakianakis G; Lyden G; Stewart Q; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Kaup H; Davies HW
    Ann Work Expo Health; 2021 Aug; 65(7):760-774. PubMed ID: 33889938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results.
    Palamini M; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2020 Dec; 26(8):1921-1930. PubMed ID: 32114883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface contamination with ten antineoplastic drugs in 83 Canadian centers.
    Chauchat L; Tanguay C; Caron NJ; Gagné S; Labrèche F; Bussières JF
    J Oncol Pharm Pract; 2019 Jul; 25(5):1089-1098. PubMed ID: 29726786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing wipe sampling strategy guidance for assessing environmental contamination of antineoplastic drugs.
    Arnold S; Jeronimo M; Astrakianakis G; Kunz M; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Davies HW
    J Oncol Pharm Pract; 2023 Dec; 29(8):1816-1824. PubMed ID: 35924415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of novel field measurement and field evaluation protocols for assessing health care workers' exposure risk to antineoplastic drugs.
    Astrakianakis G; Jeronimo M; Griffiths A; Colombo M; Kramer D; Demers PA; Hon CY
    J Occup Environ Hyg; 2020 Sep; 17(9):373-382. PubMed ID: 32615872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External contamination of antineoplastic drug containers from a Canadian wholesaler.
    Hilliquin D; Bussières JF
    J Oncol Pharm Pract; 2020 Mar; 26(2):423-427. PubMed ID: 31446868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center.
    Acramel A; Fouque J; Blondeel-Gomes S; Huguet S; Rezai K; Madar O; Escalup L
    Ann Work Expo Health; 2022 Nov; 66(9):1215-1223. PubMed ID: 35596678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States.
    Connor TH; Anderson RW; Sessink PJ; Broadfield L; Power LA
    Am J Health Syst Pharm; 1999 Jul; 56(14):1427-32. PubMed ID: 10428450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carry-over of antineoplastic drug contamination in Dutch hospital pharmacies.
    Crul M; Simons-Sanders K
    J Oncol Pharm Pract; 2018 Oct; 24(7):483-489. PubMed ID: 28454501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of surface contamination in a hospital hematology--oncology pharmacy.
    Touzin K; Bussières JF; Langlois E; Lefebvre M
    J Oncol Pharm Pract; 2009 Mar; 15(1):53-61. PubMed ID: 18772214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study.
    Roland C; Caron N; Bussières JF
    J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
    Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
    Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective.
    Schulz H; Bigelow S; Dobish R; Chambers CR
    J Oncol Pharm Pract; 2005 Sep; 11(3):101-9. PubMed ID: 16390598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of long-term data on surface contamination by antineoplastic drugs in pharmacies.
    Quartucci C; Rooney JPK; Nowak D; Rakete S
    Int Arch Occup Environ Health; 2023 Jul; 96(5):675-683. PubMed ID: 36877242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.
    Connor TH; Zock MD; Snow AH
    J Occup Environ Hyg; 2016 Sep; 13(9):658-67. PubMed ID: 27019141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.
    Viegas S; Pádua M; Veiga AC; Carolino E; Gomes M
    Environ Monit Assess; 2014 Nov; 186(11):7807-18. PubMed ID: 25096642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.
    Kiffmeyer TK; Tuerk J; Hahn M; Stuetzer H; Hadtstein C; Heinemann A; Eickmann U
    Ann Occup Hyg; 2013 May; 57(4):444-55. PubMed ID: 23125441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers.
    Pinet E; Cirtiu CM; Caron N; Bussières JF; Tanguay C
    J Oncol Pharm Pract; 2024 Jan; 30(1):19-29. PubMed ID: 37021440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.